Here the authors show that lowering IGF-1R levels in endothelial cells improves insulin sensitivity, boosts energy use, and supports beneficial changes in adipose tissue, offering insights into potential treatments for obesity-related metabolic disorders. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.